Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Crescent Biopharma, Inc. (CBIO)

13.48 -0.59 (-4.19%)
At close: October 30 at 4:00:02 PM EDT
13.48 0.00 (0.00%)
After hours: October 30 at 4:00:08 PM EDT
Trade CBIO on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
Total Revenue
11,883
10,844
Operating Expense
180,353
163,476
Operating Income
-168,470
-152,632
Net Non Operating Interest Income Expense
5,346
690
Pretax Income
-163,124
-151,942
Tax Provision
--
2,000
Net Income Common Stockholders
-165,124
-153,942
Diluted NI Available to Com Stockholders
-165,124
-153,942
Basic EPS
-0.14
-12.81
Diluted EPS
-0.14
-12.81
Basic Average Shares
24,480.68
10,413.65
Diluted Average Shares
24,480.68
10,413.65
Total Operating Income as Reported
-168,470
-152,632
Total Expenses
180,353
163,476
Net Income from Continuing & Discontinued Operation
-165,124
-153,942
Normalized Income
-165,124
-153,942
Interest Income
5,346
2,875
Interest Expense
0
2,185
Net Interest Income
5,346
690
EBIT
-163,124
-149,757
EBITDA
-162,912
-149,673
Reconciled Depreciation
212
84
Net Income from Continuing Operation Net Minority Interest
-165,124
-153,942
Normalized EBITDA
-162,912
-149,673
Tax Rate for Calcs
0
0
Tax Effect of Unusual Items
0
0
12/31/2025 - 1/10/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: